Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System
Clinical trial NCT01048554 · COMPLETED
Trial details
- NCT number
- NCT01048554
- Sponsor
- Mt. Sinai Medical Center, Miami
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2011-09-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.